Friday, April 22, 2011

UC Berkeley, Lawrence Berkeley Lab Start Synthetic Biology Institute

A new institute formed by UC Berkeley and Lawrence Berkeley National Laboratory will work to engineer cells and biological systems to tap discoveries in health, energy and new materials, among other targets. Agilent Technologies Inc. is the first corporate partner of the Synthetic Biology Institute. UC Berkeley did not say how much Santa Clara-based Agilent (NYSE: A) will pay, but it said the company made a multiyear, multimillion-dollar commitment. Led by UC Berkeley’s College of Engineering and College of Chemistry, the instititute will work to develop inexpensive drugs for treating diseases, methods for producing transportation biofuels from plants, microbes that target tumors, water purification, environmental cleanup and functional new materials. More>